65 related articles for article (PubMed ID: 31195136)
1. IL-22 Accelerates Thymus Regeneration via Stat3/Mcl-1 and Decreases Chronic Graft-versus-Host Disease in Mice after Allotransplants.
Pan B; Wang D; Li L; Shang L; Xia F; Zhang F; Zhang Y; Gale RP; Xu M; Li Z; Xu K
Biol Blood Marrow Transplant; 2019 Oct; 25(10):1911-1919. PubMed ID: 31195136
[TBL] [Abstract][Full Text] [Related]
2. Ruyong formula improves thymus function of CUMS-stimulated breast cancer mice.
He B; Guo W; Shi R; Hoffman RD; Luo Q; Hu YJ; Gao J
J Ethnopharmacol; 2024 Jan; 319(Pt 1):117164. PubMed ID: 37717843
[TBL] [Abstract][Full Text] [Related]
3. Recombinant FOXN1 fusion protein increases T cell generation in aged mice.
Zhao J; Zhang Z; Lai KC; Lai L
Res Sq; 2023 Feb; ():. PubMed ID: 36798162
[TBL] [Abstract][Full Text] [Related]
4. Circulating mature dendritic cells homing to the thymus promote thymic epithelial cells involution via the Jagged1/Notch3 axis.
Wu H; Li X; Zhou C; Yu Q; Ge S; Pan Z; Zhao Y; Xia S; Zhou X; Liu X; Wang H; Shao Q
Cell Death Discov; 2021 Aug; 7(1):225. PubMed ID: 34462426
[TBL] [Abstract][Full Text] [Related]
5. Mesenchymal stem cells reverse thymus aging by reprogramming the DNA methylation of thymic epithelial cells.
Yang Z; Tian C; He Z; Zhu X; He J; Pan H; Li Y; Ruan G; Wu X; Pan X
Regen Ther; 2024 Dec; 27():126-169. PubMed ID: 38571892
[TBL] [Abstract][Full Text] [Related]
6. Damage-induced pyroptosis drives endog thymic regeneration via induction of Foxn1 by purinergic receptor activation.
Kinsella S; Evandy CA; Cooper K; Cardinale A; Iovino L; deRoos P; Hopwo KS; Smith CW; Granadier D; Sullivan LB; Velardi E; Dudakov JA
bioRxiv; 2023 Jan; ():. PubMed ID: 36711570
[TBL] [Abstract][Full Text] [Related]
7. PD-1 antibody and ruxolitinib enhances graft-versus-lymphoma effect without increasing acute graft-versus-host disease in mice.
Pan B; Shang L; Liu C; Gao J; Zhang F; Xu M; Li L; Sun Z; Li Z; Xu K
Am J Transplant; 2021 Feb; 21(2):503-514. PubMed ID: 32805756
[TBL] [Abstract][Full Text] [Related]
8. The Role of mTOR Inhibitors in Hematologic Disease: From Bench to Bedside.
Feng Y; Chen X; Cassady K; Zou Z; Yang S; Wang Z; Zhang X
Front Oncol; 2020; 10():611690. PubMed ID: 33489922
[TBL] [Abstract][Full Text] [Related]
9. Complex interactions of cellular players in chronic Graft-versus-Host Disease.
Gail LM; Schell KJ; Łacina P; Strobl J; Bolton SJ; Steinbakk Ulriksen E; Bogunia-Kubik K; Greinix H; Crossland RE; Inngjerdingen M; Stary G
Front Immunol; 2023; 14():1199422. PubMed ID: 37435079
[TBL] [Abstract][Full Text] [Related]
10. [Chinese consensus on the diagnosis and management of chronic graft-versus-host disease (2021)].
;
Zhonghua Xue Ye Xue Za Zhi; 2021 Apr; 42(4):265-275. PubMed ID: 33979969
[No Abstract] [Full Text] [Related]
11. Evaluation of Ruxolitinib for Steroid-Refractory Chronic Graft-vs-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation.
Wu H; Shi J; Luo Y; Tan Y; Zhang M; Lai X; Yu J; Liu L; Fu H; Huang H; Zhao Y
JAMA Netw Open; 2021 Jan; 4(1):e2034750. PubMed ID: 33502484
[TBL] [Abstract][Full Text] [Related]
12. [The clinical observation of sirolimus combined with calcineurin inhibitors for steroid-resistant/steroid-dependent extensive cGVHD].
Zhu W; Feng YM; Chen T; Yao H; Quan Y; Rao J; Gao L; Zhang C; Liu Y; Gao L; Kong PY; Zhang X
Zhonghua Xue Ye Xue Za Zhi; 2020 Sep; 41(9):716-722. PubMed ID: 33113602
[No Abstract] [Full Text] [Related]
13. Antithymocyte Globulin for Matched Sibling Donor Transplantation in Patients With Hematologic Malignancies: A Multicenter, Open-Label, Randomized Controlled Study.
Chang YJ; Wu DP; Lai YR; Liu QF; Sun YQ; Hu J; Hu Y; Zhou JF; Li J; Wang SQ; Li W; Du X; Lin DJ; Ren HY; Chen FP; Li YH; Zhang X; Huang H; Song YP; Jiang M; Hu JD; Liang YM; Wang JB; Xiao Y; Huang XJ
J Clin Oncol; 2020 Oct; 38(29):3367-3376. PubMed ID: 32650683
[TBL] [Abstract][Full Text] [Related]
14. Ruxolitinib for Glucocorticoid-Refractory Acute Graft-versus-Host Disease.
Zeiser R; von Bubnoff N; Butler J; Mohty M; Niederwieser D; Or R; Szer J; Wagner EM; Zuckerman T; Mahuzier B; Xu J; Wilke C; Gandhi KK; Socié G;
N Engl J Med; 2020 May; 382(19):1800-1810. PubMed ID: 32320566
[TBL] [Abstract][Full Text] [Related]
15. [The clinical observation of serum specific biomarkers in patients with chronic graft-versus-host disease].
Chen T; Li XP; Zhang C; Kong PY; Gao QG; Tang L; Wang R; Yang SJ; Gao L; Liu Y; Gao L; Feng YM; Rao J; Peng XG; Zhang X
Zhonghua Xue Ye Xue Za Zhi; 2019 Nov; 40(11):948-952. PubMed ID: 31856446
[No Abstract] [Full Text] [Related]
16. Two dose levels of rabbit antithymocyte globulin as graft-versus-host disease prophylaxis in haploidentical stem cell transplantation: a multicenter randomized study.
Lin R; Wang Y; Huang F; Fan Z; Zhang S; Yang T; Xu Y; Xu N; Xuan L; Ye J; Sun J; Huang X; Liu Q
BMC Med; 2019 Aug; 17(1):156. PubMed ID: 31401973
[TBL] [Abstract][Full Text] [Related]
17. Allogeneic Bone Marrow Transplantation versus Peripheral Blood Stem Cell Transplantation for Hematologic Malignancies in Children: A Systematic Review and Meta-Analysis.
Shimosato Y; Tanoshima R; Tsujimoto SI; Takeuchi M; Shiba N; Kobayashi T; Ito S
Biol Blood Marrow Transplant; 2020 Jan; 26(1):88-93. PubMed ID: 31394270
[TBL] [Abstract][Full Text] [Related]
18. Primary and secondary defects of the thymus.
Dinges SS; Amini K; Notarangelo LD; Delmonte OM
Immunol Rev; 2024 Mar; 322(1):178-211. PubMed ID: 38228406
[TBL] [Abstract][Full Text] [Related]
19. Aryl hydrocarbon receptor regulates IL-22 receptor expression on thymic epithelial cell and accelerates thymus regeneration.
Shen J; Wang Y; Zheng F; Cao S; Lan Q; Xu K; Pan B
NPJ Regen Med; 2023 Nov; 8(1):64. PubMed ID: 37938575
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
